# OnCo record proxygen (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/proxygen/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "proxygen" ;
  schema:name "Proxygen"@en ;
  schema:description "Proxygen is a Vienna company that hunts for molecular glues, small molecules that make cells destroy cancer-driving proteins. Its two lead programmes, against p300 and CDK12, are still in the laboratory."@en ;
  schema:url <https://onco.cc/companies/proxygen/>, <https://proxygen.com/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://proxygen.com/>, <https://proxygen.com/pipeline-beyond>, <https://proxygen.com/chronicle?post=532> ;
  schema:addressCountry "AT" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/urothelial/>, <https://onco.cc/cancers/breast-her2-positive/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/>, <https://onco.cc/fronts/epigenetics/> ;
  onco:technologies <https://onco.cc/technologies/protac-degrader/>, <https://onco.cc/technologies/epigenetic-drugs/> .